Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.

Beatriz Vaquerizo; Antonio Barros; Sandra Pujadas; Ester Bajo; Darlene Estrada; F Miranda-Guardiola; Juan Rigla; Marcelo Jiménez; Juan Cinca; Antonio Serra; Marcelo A. Jimenez

doi:10.4244/EIJY14M12_07

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.

Beatriz Vaquerizo
, Antonio Barros
, Sandra Pujadas
, Ester Bajo
, Darlene Estrada
, F Miranda-Guardiola
, Juan Rigla
, Marcelo Jiménez
, Juan Cinca
, Antonio Serra
, Marcelo A. Jimenez

Cardiology Department, Hospital Sant Pau, Barcelona, Spain.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Eurointervention
Volume	11
Issue number	5
DOIs	https://doi.org/10.4244/EIJY14M12_07
State	Published - Sep 1 2015

Disciplines

Medicine and Health Sciences
Radiology

Access to Document

10.4244/EIJY14M12_07License: Unspecified

Cite this

@article{c3092e0d0e344cafadec3e4e67984434,

title = "Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.",

author = "Beatriz Vaquerizo and Antonio Barros and Sandra Pujadas and Ester Bajo and Darlene Estrada and F Miranda-Guardiola and Juan Rigla and Marcelo Jim{\'e}nez and Juan Cinca and Antonio Serra and Jimenez, \{Marcelo A.\}",

note = "Aims: We sought to assess the safety and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) in percutaneous chronic total occlusion (CTO) revascularisation guided by intracoronary imaging. The feasibility of using the BVS in CTO lesions is unknown. Methods and results: Thirty-five consecutive true CTO lesions (EuroCTO Club definition) were included in this prospective registry.",

year = "2015",

month = sep,

day = "1",

doi = "10.4244/EIJY14M12\_07",

language = "American English",

volume = "11",

journal = "Eurointervention",

issn = "1969-6213",

publisher = " Europa Group",

number = "5",

}

TY - JOUR

T1 - Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.

AU - Vaquerizo, Beatriz

AU - Barros, Antonio

AU - Pujadas, Sandra

AU - Bajo, Ester

AU - Estrada, Darlene

AU - Miranda-Guardiola, F

AU - Rigla, Juan

AU - Jiménez, Marcelo

AU - Cinca, Juan

AU - Serra, Antonio

AU - Jimenez, Marcelo A.

N1 - Aims: We sought to assess the safety and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) in percutaneous chronic total occlusion (CTO) revascularisation guided by intracoronary imaging. The feasibility of using the BVS in CTO lesions is unknown. Methods and results: Thirty-five consecutive true CTO lesions (EuroCTO Club definition) were included in this prospective registry.

PY - 2015/9/1

Y1 - 2015/9/1

UR - https://pubmed.ncbi.nlm.nih.gov/25499833/

U2 - 10.4244/EIJY14M12_07

DO - 10.4244/EIJY14M12_07

M3 - Article

SN - 1969-6213

VL - 11

JO - Eurointervention

JF - Eurointervention

IS - 5

ER -

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.

Disciplines

Access to Document

Other files and links

Cite this